The Institute for Clinical and Economic Review has opened nominations for membership on their New England Comparative Effectiveness Public Advisory Council. New England CEPAC meets three times each year in public forums across the region to assess the evidence for treatments for specific conditions with input from stakeholders including patients affected by the condition. In each meeting, New England CEPAC reviews the impact of treatments, including drugs, on the region’s population and economy. Many payers are using ICER and New England CEPAC’s work in developing coverage and payment policies for new treatments. Click here to learn more about ICER’s process to choose topics and here for more on New England CEPAC’s process. ICER provides members with travel reimbursement and an honorarium for CEPAC meetings. For nominations, click here. Nominations are open through January 10th.